Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-20

Clinical Trial Update: Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing radiation therapy and chemotherapy with or without cetuximab followed by surgery in locally advanced resectable esophageal cancer; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | Phase 3 | Status: COMPLETED